An update on the pharmacotherapeutic options for complex regional pain syndrome

被引:6
作者
Iolascon, Giovanni [1 ]
Snichelotto, Francesco [1 ]
Moretti, Antimo [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Med & Surg Specialties & Dent, Via De Crecchio 6, I-80138 Naples, Italy
关键词
Algodystrophy; anesthetics; antidepressants; bisphosphonates; complex regional pain syndromes; drug therapy; NSAIDs; opioids; SYNDROME TYPE-I; REFLEX SYMPATHETIC DYSTROPHY; BOTULINUM-TOXIN-A; INTRAVENOUS IMMUNOGLOBULIN TREATMENT; DOUBLE-BLIND; SYNDROME TYPE-1; NEUROPATHIC PAIN; SPINAL-CORD; VITAMIN-C; MANAGEMENT;
D O I
10.1080/14737175.2024.2307490
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionComplex regional pain syndrome (CRPS) is a rare and painful condition that has a wide range of triggering factors, often traumatic, and can present various clinical manifestations. The lack of knowledge about the underlying mechanisms has led to numerous treatment approaches, both conservative and surgical, which work through different mechanisms of action.Areas coveredIn this review, the authors explore the key aspects of CRPS, including definition, diagnostic criteria, pitfalls, pathogenic hypotheses, and treatment strategies with a focus on pharmacotherapy. The review was based on a comprehensive search of the literature using PubMed, while also considering international guidelines for managing CRPS.Expert opinionBased on the available evidence, pharmacological interventions appear to be effective in treating CRPS, especially when they target peripheral mechanisms, specifically nociceptive inflammatory pain, and when administered early in the course of the disease. However, there is still a lack of reliable evidence regarding the effects of drugs on central mechanisms of chronic pain in CRPS. In our expert opinion, drug therapy should be initiated as soon as possible, particularly in warm CRPS patient clusters, to prevent significant functional limitations, psychological distress, and negative impacts on individuals' social and economic well-being.
引用
收藏
页码:177 / 190
页数:14
相关论文
共 128 条
  • [1] aaos, 2009, TREATMENT DISTAL RAD
  • [2] [Anonymous], MED LETT DRUGS THER, V55, P29
  • [3] Alternative analgesics: New drugs for pain seek to improve on ketamine's benefits
    Arnold, Carrie
    [J]. NATURE MEDICINE, 2017, 23 (01) : 8 - 10
  • [4] Atalay NS, 2014, PAIN PHYSICIAN, V17, P179
  • [5] Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial
    Attal, Nadine
    de Andrade, Daniel C.
    Adam, Frederic
    Ranoux, Daniele
    Teixeira, Manoel J.
    Galhardoni, Ricardo
    Raicher, Irina
    Ueceyler, Nurcan
    Sommer, Claudia
    Bouhassira, Didier
    [J]. LANCET NEUROLOGY, 2016, 15 (06) : 555 - 565
  • [6] The Treatment of Longstanding Complex Regional Pain Syndrome with Oral Steroids
    Barbalinardo, Stefania
    Loer, Stephan A.
    Goebel, Andreas
    Perez, Roberto S. G. M.
    [J]. PAIN MEDICINE, 2016, 17 (02) : 337 - 343
  • [7] Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): Prospective study on 596 patients with a fracture
    Beerthuizen, Annemerle
    Stronks, Dirk L.
    van't Spijker, Adriaan
    Yaksh, Ameeta
    Hanraets, Barbara M.
    Klein, Jan
    Huygen, Frank J. P. M.
    [J]. PAIN, 2012, 153 (06) : 1187 - 1192
  • [8] Intra-articular botulinum toxin injection in complex regional pain syndrome: Case report and review of the literature
    Bellon, Giulia
    Venturin, Andrea
    Masiero, Stefano
    Del Felice, Alessandra
    [J]. TOXICON, 2019, 159 : 41 - 44
  • [9] Evolving Definitions and Pharmacologic Management of Complex Regional Pain Syndrome
    Benzon, Honorio T.
    Liu, Spencer S.
    Buvanendran, Asokumar
    [J]. ANESTHESIA AND ANALGESIA, 2016, 122 (03) : 601 - 604
  • [10] The important role of neuropeptides in complex regional pain syndrome
    Birklein, F
    Schmelz, M
    Schifter, S
    Weber, M
    [J]. NEUROLOGY, 2001, 57 (12) : 2179 - 2184